Europe Prebiotics for Infant Formula Market – Industry Trends and Forecast to 2027

  • Food & Beverage
  • Published Report
  • Dec 2019
  • Europe
  • 350 Pages
  • No of Tables: 190
  • No of Figures: 25

Europe Prebiotics for Infant Formula By Type (Human Milk Oligosaccharides (HMOS), Galactooligosaccharides (GOS), Fructooligosaccharides (FOS), Mannan-Oligosaccharides (MOS), Polydextrose (PDX), Lactulose (LOS), Inulin), Source (Bacteria, Algae, Fungi, Plants & Vegetables), Grade (Inorganic, Organic), Form (Powder, Liquid), Product Type (Standard Formula, Toddler Formula, Follow Up Formula, Special Formula), Infant Age (0-6 Months, 6-12 Months, 1-3 Years), By Country (Germany, U.K., France, Italy, Spain, Denmark, Netherlands, Switzerland, Poland, Russia, Sweden, Belgium, Turkey and Rest of Europe), Market Trends and  Forecast to 2027

Market Analysis and Insights: Europe Prebiotics for Infant Formula Market

Prebiotics for Infant Formula market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing at a CAGR of 6.1% in the forecast period of 2020 to 2027and expected to reach USD 369.57 million by 2027. Rising approval of prebiotics and their implementation as Generally Recognized as Safe (GRAS) in infant formulations are the factors augmented towards market growth.

The prebiotics offers rich source of nutrition for infants through the formula which is creating huge demand for products in Europe market. The prebiotics such as Oligosaccharides in human milk offers intestinal development. The guidelines published by the European Commission and according to standards fructo-oligosaccharides and galacto-oligosaccharides prebiotics used in the infant formula must not exceed the limit which is 0.8 g/100 ml having combination of 10 % high molecular weight oligofructosyl-saccharose and 90 % oligogalactosyl-lactose.

This prebiotics for infant formula market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Europe Prebiotics for Infant Formula Market Scope and Market Size

Prebiotics for Infant Formula market is segmented of the basis type, source, grade, form, product type and infant age. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the market is segmented into human milk oligosaccharides (HMOS), galactooligosaccharides (GOS), fructooligosaccharides (FOS), mannan-oligosaccharides (MOS), polydextrose (PDX), lactulose (LOS), and inulin. In 2020 Human milk oligosaccharides (HMOS) segment is expected to dominate the market and growing with highest CAGR due to their composition associated with the human milk and benefits adapted for the infant’s immature digestive and immune systems. In March 2018, DuPontand Inbiose NV (Belgium) announced their European Regulatory approval of EU regulatory approval first human milk oligosaccharides (HMOS) for infant formula. The approval of the product is expected to fulfil the nutritional demand of the infants.
  •  On the basis of source, the market is segmented into bacteria, algae, fungi, plants & vegetables, and others. In 2020, plants & vegetables segment is expected to dominate the market due to the high yield of FOS & GOS from Barley, wheat and extraction of Inulin from Chicory roots. For instance, In September 2018, Jennewein Biotechnologie GmbH developed new fermentation technology suitable for the human milk oligosaccharides. The new fermentation is developed from the simple carbon sources instead of the lactose which is costly dairy by-product as well as difficult to handle. Through this the company enhanced their product portfolio as well as saved cost of production by using less cost material.
  • On the basis of grade, the market is segmented into inorganic and organic. In 2020, inorganic segment is expected to dominate the market and in Europe and Organic segment is growing with the highest CAGR, due to the availability and processing of the prebiotics as it is produced by enzymatic procedures with the involvement of the bacterial strain in manufacturing processes, whereas, high demand of the vegan products due to the growing vegan population and safety associated with the organic products is convincing population to prefer organic product which lead to grow with highest CAGR.
  • On the basis of form, the market is segmented into powder and liquid. In 2020, powder segment is expected to dominate the market as according food additive safety (HFS-255), FOS is majorly marketed in form of granular form due to their stability and consistency to manufacture the infant formula in off-white color. With the stability and ease in handling the powder form is most preferable choice among manufacturers than the liquid.
  • On the basis of product type, the market is segmented into standard formula, toddler formula, follow up formula and special formula. In 2020, standard formula segment is expected to dominate due to their similar efficiency in growth and development of infants and the formulation composition of prebiotics in standard formulas compare to other shows positive effect in developing the gut bacteria. The standard formula and their adoption among infants of age 0 to 12 months incorporated with FOS and GOS blends provide positive feedback and leading in their health growth

Prebiotics for Infant Formula Market Country Level Analysis

Prebiotics for infant formula market is analysed and market size information is provided by country by type, source, grade, form, product type and infant age as referenced above.

The countries covered in the prebiotics for infant formula market report are Germany, U.K., France, Italy, Spain, Denmark, Netherlands, Switzerland, Poland, Russia, Sweden, Belgium, Turkey and Rest of Europe.

In European Market, Germany is dominating the market and growing with the highest CAGR due to the major approval of the HMOs, FOS and GOS in infant formulations. The companies are investing in the European market to introduce their products due to preferences and demand of plant based products .For instance, according to the BENEO Company a Subsidiary of Südzucker AG (Germany), in June 2019, almost 64 percent of European consumers think that digestive system is the most important factor for healthy immune system due to which they are ready to spend extra money for healthy food. As a result, BONEO offers wide range of prebiotics for infant nutrition based on the chicory root fiber.

Prebiotics for Infant Formula Market, By Product Type

Prebiotics for Infant Formula Market

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of European brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growth in Utilization of Clinical Laboratories

Europe prebiotics for infant formula market also provides you with detailed market analysis for every country growth in installed base of different kind of products for prebiotics for infant formula market, impact of technology using life line curves and changes in infant formula regulatory scenarios and their impact on the prebiotics for infant formula market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Prebiotics for Infant Formula Market Share Analysis

Europe prebiotics for infant formula market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, brand analysis, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Europe prebiotics for infant formula market.

The major players covered in the report are Jennewein Biotechnologie GmbH, zuChem Inc., Biosynth Carbosynth, ELICITYL SA, Dextra Laboratories Limited, Glycom A/S, Tereos, Ingredion Incorporated, Royal FrieslandCampina N.V., Südzucker AG, Cargill, Incorporated., Fonterra Co-operative Group, Royal Cosun, COSUCRA, New Francisco (Yunfu City) Biotechnology Corporation Limited, Dana Dairy Group, Glycosyn LLC and DuPont among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

For instance,

  • In October 2019, Biosynth Carbosynth (U.K.) announced new development to improve the operational handling of organisation. The company introduced research products division separated from the pharmaceutical and diagnostic products division to transactional business. Through this company enhanced their service offering and support for global Europe customer base.

Partnership, collaboration and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for prebiotics for infant formula through expanded model range.

Customization Available : Europe Prebiotics for Infant Formula Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 2 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 3 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 4 EUROPE FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 5 EUROPE FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 6 EUROPE FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 7 EUROPE GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 8 EUROPE GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 9 EUROPE INULIN IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 10 EUROPE POLYDEXTROSE (PDX) IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 11 EUROPE MANNAN-OLIGOSACCHARIDES (MOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 12 EUROPE LACTULOSE (LOS) IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 13 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 14 EUROPE PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 15 EUROPE PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 16 EUROPE BACTERIA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 17 EUROPE FUNGI IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 18 EUROPE ALGAE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 19 EUROPE OTHERS IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 20 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 21 EUROPE INORGANIC IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 22 EUROPE ORGANIC IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 23 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 24 EUROPE POWDER IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 25 EUROPE LIQUID IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 26 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 27 EUROPE STANDARD FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 28 EUROPE SPECIAL FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 29 EUROPE FOLLOW UP FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 30 EUROPE TODDLER FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 31 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 32 EUROPE 6-12 MONTHS IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 33 EUROPE 0-6 MONTHS IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 34 EUROPE 1-3 YEARS IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 35 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY COUNTRY,  2018-2027 (USD MILLION)

TABLE 36 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 37 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 38 EUROPE FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 39 EUROPE GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 40 EUROPE FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 41 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027  (USD MILLION)

TABLE 42 EUROPE PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 43 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 44 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 45 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 46 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 47 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 48 GERMANY HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 49 GERMANY FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 50 GERMANY GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 51 GERMANY FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 52 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 53 GERMANY PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 54 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 55 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 56 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 57 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 58 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 59 U.K. HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 60 U.K. FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 61 U.K. GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 62 U.K. FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 63 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 64 U.K. PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 65 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 66 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 67 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 68 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 69 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 70 FRANCE HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 71 FRANCE FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 72 FRANCE GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 73 FRANCE FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 74 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 75 FRANCE PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 76 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 77 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 78 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 79 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 80 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 81 ITALY HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 82 ITALY FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 83 ITALY GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 84 ITALY FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 85 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 86 ITALY PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 87 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 88 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 89 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 90 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 91 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 92 SPAIN HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 93 SPAIN FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 94 SPAIN GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 95 SPAIN FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 96 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 97 SPAIN PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 98 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 99 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 100 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 101 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 102 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 103 DENMARK HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 104 DENMARK FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 105 DENMARK GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 106 DENMARK FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 107 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 108 DENMARK PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 109 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 110 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 111 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 112 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 113 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 114 NETHERLANDS HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 115 NETHERLANDS FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 116 NETHERLANDS GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 117 NETHERLANDS FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 118 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 119 NETHERLANDS PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 120 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 121 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 122 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 123 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 124 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 125 SWITZERLAND HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 126 SWITZERLAND FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 127 SWITZERLAND GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 128 SWITZERLAND FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 129 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 130 SWITZERLAND PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 131 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 132 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 133 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 134 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 135 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 136 POLAND HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 137 POLAND FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 138 POLAND GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 139 POLAND FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 140 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 141 POLAND PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 142 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 143 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 144 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 145 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 146 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 147 RUSSIA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 148 RUSSIA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 149 RUSSIA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 150 RUSSIA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 151 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 152 RUSSIA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 153 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 154 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 155 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 156 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 157 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 158 SWEDEN HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 159 SWEDEN FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 160 SWEDEN GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 161 SWEDEN FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 162 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 163 SWEDEN PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 164 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 165 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 166 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 167 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 168 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 169 BELGIUM HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 170 BELGIUM FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 171 BELGIUM GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 172 BELGIUM FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 173 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 174 BELGIUM PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 175 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 176 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 177 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 178 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 179 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 180 TURKEY HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 181 TURKEY FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

TABLE 182 TURKEY GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 183 TURKEY FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 184 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE,  2018-2027 (USD MILLION)

TABLE 185 TURKEY PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET,  BY SOURCE, 2018-2027 (USD MILLION)

TABLE 186 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE,  2018-2027 (USD MILLION)

TABLE 187 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM,  2018-2027 (USD MILLION)

TABLE 188 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE,  2018-2027 (USD MILLION)

TABLE 189 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE,  2018-2027 (USD MILLION)

TABLE 190 REST OF EUROPE PREBIOTICS FOR INFANT FORMULA MARKET,  BY TYPE, 2018-2027 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19